Trial intelligence / Profile preview

Motor Network Physiology Characterization During Deep Brain Stimulation Surgery

NCT04957095Recruiting

Sponsor
UT Southwestern Medical Center
Start
Feb 2022
Primary completion
Dec 2027
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of apomorphine and levodopa in Parkinson's disease (PD), sponsored by UT Southwestern Medical Center. Primary endpoints: Cortical ECoG and subcortical recordings and Behavioral assessment. Started Feb 2022; status: recruiting.

02

Drugs

apomorphinelevodopa
03

Conditions

Parkinson's disease (PD)

Beyond the preview

Go deeper on NCT04957095.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04957095.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call